Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 9/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.83 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.81 |
| ▸ | CA1 | P00915 | 2/20 | 0.76 |
| ▸ | CA2 | P00918 | 2/20 | 0.76 |
| ▸ | CA9 | Q16790 | 2/20 | 0.76 |
| ▸ | LMNA | P02545 | 4/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.75 |
| ▸ | ESR1 | P03372 | 5/20 | 0.73 |
| ▸ | PGR | P06401 | 2/20 | 0.73 |
| ▸ | AR | P10275 | 2/20 | 0.73 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.73 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.73 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.73 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.73 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.73 |
| ▸ | ATM | Q13315 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E2Mate SCHEMBL19272474 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL5165269 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL6866434 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL5980613 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL29924099 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL5151234 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL10070158 | 1.00 | STS (1.00) | STSABCC1ABCC4KDM4ECA1 | |
| Emate SCHEMBL7164522 | 0.93 | STS (0.86) | STSABCC1ABCC4KDM4ECA1 | |
| E2Mate SCHEMBL15940838 | 0.91 | STS (0.83) | STSABCC1ABCC4KDM4ECA1 | |
| SCHEMBL232796 | 0.91 | ABCC4 (1.00) | STSABCC1ABCC4KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119701013-A | Estrogen-beta-cyclodextrin inclusion compound, preparation method thereof and tablets | 浙江仙琚制药股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| EP-2062569-B1 | Vaginal delivery system | BAYER OY (FI) | 2011-05-11 | — | — | EP | claimed |
| US-20110097405-A1 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2011-04-28 | — | — | US | claimed |
| EP-2249803-A2 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-11-17 | — | — | EP | claimed |
| US-20100285097-A1 | VAGINAL DELIVERY SYSTEM | BAYER OY (FI) | 2010-11-11 | — | — | US | claimed |
| EP-2227220-A1 | VAGINAL DELIVERY SYSTEM | Bayer Schering Pharma Oy (FI) | 2010-09-15 | — | — | EP | claimed |
| WO-2009101021-A2 | ESTRADIOL-CONTAINING DRUG DELIVERY SYSTEM | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2009-08-20 | — | — | WO | claimed |
| US-20090142313-A1 | VAGINAL DELIVERY SYSTEM | BAYER SCHERING PHARMA OY (FI) | 2009-06-04 | — | — | US | claimed |
| WO-2009066006-A1 | VAGINAL DELIVERY SYSTEM | BAYER SCHERING PHARMA OY (FI) | 2009-05-28 | — | — | WO | claimed |
| EP-2062569-A1 | Vaginal delivery system | Bayer Schering Pharma Oy (FI) | 2009-05-27 | — | — | EP | claimed |
| EP-1100509-B1 | USE OF BIOGENIC ESTROGEN SULFAMATES FOR HORMONE REPLACEMENT THERAPY | SCHERING AG (DE) | 2005-04-06 | — | — | EP | claimed |
| US-6841548-B2 | Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives | SCHERING AG (DE) | 2005-01-11 | — | — | US | claimed |
| EP-1456224-A2 | INDUSTRIALLY APPLICABLE PROCESS FOR THE SULFAMOYLATION OF ALCOHOLS AND PHENOLS | Schering Aktiengesellschaft (DE) | 2004-09-15 | — | — | EP | claimed |
| US-20030171346-A1 | Industrially applicable process for the sulfamoylation of alcohols and phenols | SCHERING AG (DE) | 2003-09-11 | — | — | US | claimed |
| WO-2003053992-A2 | INDUSTRIALLY APPLICABLE PROCESS FOR THE SULFAMOYLATION OF ALCOHOLS AND PHENOLS | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-07-03 | — | — | WO | claimed |
| CN-1404394-A | Composition comprising a metal oxide and a metal oxide | STERIX LTD (GB) | 2003-03-19 | — | — | CN | claimed |
| US-20020061868-A1 | Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives | STERIX LIMITED (GB) | 2002-05-23 | — | — | US | claimed |
| US-6080735-A | SUITABLE FOR HORMONAL CONTRACEPTION AND CLIMACTERIC HORMONE REPLACEMENT THERAPY (HRT) AS WELL AS FOR TREATMENT OF GYNECOLOGICAL AND ANDROLOGICAL DISEASES | JENAPHARM GMBH & CO. KG (DE) | 2000-06-27 | — | — | US | claimed |
| EP-0889727-A1 | SEQUENTIAL OESTROGEN/PROGESTERONE ANTAGONIST COMBINATION FOR HORMONE REPLACEMENT THERAPY | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-01-13 | — | — | EP | claimed |
| WO-1997033589-A1 | SEQUENTIAL OESTROGEN/PROGESTERONE ANTAGONIST COMBINATION FOR HORMONE REPLACEMENT THERAPY | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-09-18 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020061868-A1 | Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives | ESRRA, ESR2, CYP19A1 | STS 124/4885ABCC1 819/4885ABCC4 2078/4885 |
| US-20030171346-A1 | Industrially applicable process for the sulfamoylation of alcohols and phenols | HSD17B11, ADH1C, ADH1A | STS 5/4885ABCC1 4806/4885ABCC4 4865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.